Avanos Medical (AVNS) Gross Margin (2013 - 2026)
Avanos Medical recorded quarterly Gross Margin of 51.7% in Q1 2026, up 8.75% quarter-over-quarter from 47.54% in Q4 2025, and down 191.0% year-over-year from 56.81% in Q1 2025.
Avanos Medical's Gross Margin history runs 14 years deep, the most recent figure standing at 51.7% for Q1 2026.
- In Q1 2026, Gross Margin fell 191.0% year-over-year to 51.7%; the TTM figure through Mar 2026 stood at 50.05% (down 455.0% YoY), while the FY2025 annual figure was 50.47%, down 497.0% from the prior year.
- Gross Margin came in at 51.7% for Q1 2026 at Avanos Medical, up from 47.54% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 59.45% in Q2 2022 to a low of 47.54% in Q4 2025.
- A 5-year average of 54.68% and a median of 54.82% in 2023 frame the typical range for Gross Margin.
- On a YoY basis, Gross Margin climbed as much as 1347 bps in 2022 and fell as far as 3356 bps in 2022.
- Avanos Medical's Gross Margin stood at 56.66% in 2022, then retreated by 3 bps to 54.82% in 2023, then decreased by 0 bps to 54.57% in 2024, then fell by 13 bps to 47.54% in 2025, then gained by 9 bps to 51.7% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 51.7%, 47.54%, and 48.37% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 51.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.70% |
| Dec 31, 2025 | 47.54% |
| Sep 30, 2025 | 48.37% |
| Jun 30, 2025 | 52.63% |
| Mar 31, 2025 | 53.61% |
| Dec 31, 2024 | 54.57% |
| Sep 30, 2024 | 54.52% |
| Jun 30, 2024 | 55.68% |
| Mar 31, 2024 | 57.07% |
| Dec 31, 2023 | 54.82% |
| Sep 30, 2023 | 55.75% |
| Jun 30, 2023 | 57.73% |
| Mar 31, 2023 | 57.38% |
| Dec 31, 2022 | 56.66% |
| Sep 30, 2022 | 58.15% |
| Jun 30, 2022 | 59.45% |
| Mar 31, 2022 | 54.00% |
| Dec 31, 2021 | 90.22% |
| Sep 30, 2021 | 49.00% |
| Jun 30, 2021 | 45.98% |
| Mar 31, 2021 | 50.53% |
| Dec 31, 2020 | 46.76% |
| Sep 30, 2020 | 51.59% |
| Jun 30, 2020 | 52.84% |
| Mar 31, 2020 | 56.60% |
| Dec 31, 2019 | 57.80% |
| Sep 30, 2019 | 55.43% |
| Jun 30, 2019 | 57.32% |
| Mar 31, 2019 | 60.17% |
| Dec 31, 2018 | 59.09% |
| Sep 30, 2018 | 63.42% |
| Jun 30, 2018 | 58.86% |
| Mar 31, 2018 | 58.25% |
| Dec 31, 2017 | 54.06% |
| Sep 30, 2017 | 53.82% |
| Jun 30, 2017 | 56.67% |
| Mar 31, 2017 | 55.94% |
| Dec 31, 2016 | 19.15% |
| Sep 30, 2016 | 34.72% |
| Jun 30, 2016 | 35.18% |
| Mar 31, 2016 | 35.47% |
| Dec 31, 2015 | 21.11% |
| Sep 30, 2015 | 33.63% |
| Jun 30, 2015 | 34.65% |
| Mar 31, 2015 | 33.51% |
| Dec 31, 2014 | 35.62% |
| Sep 30, 2014 | 32.36% |
| Jun 30, 2014 | 25.37% |
| Mar 31, 2014 | 37.74% |
| Dec 31, 2013 | 36.01% |
| Sep 30, 2013 | 38.50% |